A meta-analysis of highly active anti-retroviral therapy for treatment of plasmablastic lymphoma

Delecluse, 1997, Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection, Blood, 89, 1413, 10.1182/blood.V89.4.1413 Kim, 2009, Human immunodeficiency virus-negative plasmablastic lymphoma in Korea, Leuk Lymphoma., 50, 582, 10.1080/10428190902789173 Kane, 2009, Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a developing country, J Oral Pathol Med., 38, 138, 10.1111/j.1600-0714.2008.00673.x Bose, 2009, AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib, Eur J Haematol., 82, 490, 10.1111/j.1600-0609.2009.01235.x Carbone, 2002, AIDS-related non-Hodgkin's lympho-mas: from pathology and molecular pathogenesis to treatment, Hum Pathol., 33, 392, 10.1053/hupa.2002.124723 Rafaniello Raviele, 2009, Plasmablastic lymphoma: a review, Oral Dis., 15, 38, 10.1111/j.1601-0825.2008.01493.x Dong, 2005, Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm, Am J Surg Pathol., 29, 1633, 10.1097/01.pas.0000173023.02724.1f Carbone, 2001, Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histoge-netic subsets of human immunodeficiency virus-related lymphomas, Blood., 97, 744, 10.1182/blood.V97.3.744 Carbone, 2004, Is plasmablastic lymphoma of the oral cavity an HHV-8-as-sociated disease?, Am J Surg Pathol, 28, 1538, 10.1097/01.pas.0000131533.21345.1c DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials., 7, 177, 10.1016/0197-2456(86)90046-2 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med., 21, 15391558, 10.1002/sim.1186 Kjaergard, 2001, Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses, Ann Intern Med., 135, 982, 10.7326/0003-4819-135-11-200112040-00010 Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials., 17, 1, 10.1016/0197-2456(95)00134-4 Chetty, 2003, Plasmablastic lymphoma in HIV+ patients: an expanding spectrum, Histopathology., 42, 605, 10.1046/j.1365-2559.2003.01636.x Cioc, 2004, Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8, Am J Surg Pathol., 28, 41, 10.1097/00000478-200401000-00003 Folk, 2006, Plasmablastic lymphoma: a clinicopathologic correlation, Ann Diagn Pathol., 10, 8, 10.1016/j.anndiagpath.2005.07.009 Gaidano, 2002, Molecular histogenesis of plasmablastic lymphoma of the oral cavity, Br J Haematol., 119, 622, 10.1046/j.1365-2141.2002.03872.x Riedel, 2008, Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection, Lancet Infect Dis., 8, 261, 10.1016/S1473-3099(08)70067-7 Teruya-Feldstein, 2005, Diffuse large B-cell lymphomas with plasmablastic differentiation, Curr Oncol Rep., 7, 357, 10.1007/s11912-005-0062-5 Castillo, 2008, HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases, Am J Hematol., 83, 804, 10.1002/ajh.21250 Mani, 2008, AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma, World J Gastroenterol., 14, 4395, 10.3748/wjg.14.4395 Goedhals, 2008, HHV8 in plasmablastic lymphoma, Am J Surg Pathol, 32, 172, 10.1097/PAS.0b013e3180dc92c4 Carbone, 2008, Plasmablastic lymphoma: one or more entities?, Am J Hematol., 83, 763, 10.1002/ajh.21259